14159, L.P.
SEC-identified person · CIK 1551138 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Genomic Health INC GHDX | Director | filed 2012–2019 |
| Incyte Corp INCY | Director | filed 2013–2019 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2014–2019 |
| Acadia Pharmaceuticals INC ACAD | Director | filed 2013–2018 |
| Beigene, Ltd. ONC | Director | filed 2016–2017 |
| Xoma Royalty Corp XOMAD | Director | filed 2012–2015 |
| Trimeris INC TRMS | Director | filed 2012–2015 |
| Seagen Inc. SGEN | Director | filed 2013–2014 |
| Biocryst Pharmaceuticals INC BCRX | Officer | filed 2013–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.